Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voxelotor in Sickle Cell Disease (HEMOPROVE)
NCT05199766Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of voxelotor in sickle cell disease (SCD), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
voxelotor
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT05199766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05199766.